Authors
Loading...
Preclinical study demonstrates that Th17 cells and interleukin-17 drive atherosclerotic plaque formation in mice, suggesting targeting interleukin-17 could treat atherosclerosis.
Gao et al. (2010) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: